Diagnostic Accuracy of Procalcitonin, Neutrophil-to-Lymphocyte Ratio, and C-Reactive Protein in Detection of Bacterial Infections and Prediction of Outcome in Nonneutropenic Febrile Patients with Lung Malignancy

Table 7

The treatment and clinical response in bacteria-infected subgroup B.

	Response to therapy				Total
	PD	SD	PR	unknown
Treatment					191
Radiotherapy	20	23	2	17	62
Chemotherapy	14	21	3	12	50
Surgery					66
Others^a					13

^aRefer mainly to targeted combination, conservative treatment, or suspension therapy. PD: progressive disease; SD: stable disease; PR: partial response.